Two genes encoding for aminoglycoside-(3>N-acctyltran8ferases (AAC(3)s) of different substrate patterns, present in multiresistance plasmids of hospital strains of Serratia marcescens and Escherichia coli isolated from urine, have been cloned and characterized. The first, aacCl with AAQ3)I activity, contained a S31 base pair open reading frame which encodes a polypeptidc of 177 aminoacids and 19,392 daltons, confirmed by minicell analysis. Its sequence differed from previously published work in four positions. Three of the changes did not alter the aminoacid sequence while the fourth was a substitution of an alanine by a proline. The second gene, an AAQ3)II encoded by aacC2, resulted from the translation of an 8S8 base pair open reading frame, which encoded a 286 aminoacid polypeptide of 31,574 daltons and was identical to those from plasmids isolated in Germany and the United States. However, the homology was broken in a position between the -10 and -35 promoter sequences, which resulted in different -35 hexanucleotides and levels of resistance conferred. The assay of both genes as molecular probes has revealed their specificity with respect to other aac genes, although their usefulness was limited in the case of aacCX derived sequences to isolated plasmid DNA, since it hybridized under stringent conditions with chromosomal DNA of some strains of E. coli.
Introduction
The most common mechanisms of resistance to aminoglycoside-aminocyclitol (AG) antibiotics in bacteria are exerted by enzymatic modification which results in failure of their binding to ribosomal targets and in prevention of uptake by the cell (Dickie, Bryan & Pickard, 1978) . The structural genes of the modifying enzymes (AGMEs) are usually located on plasmids and/or transposons which enhance their spread into hospital bacteria, including species with no genetic relationship (Davies & Smith, 1978; Foster, 1983; Bryan, 1984; Phillips & Shannon, 1984) . In the hospitals in this community, acetylation of the amino-group in position 3 of 2-deoxystreptamine moiety of aminoglycosides (AAC (3)) has been detected among Gram-negative bacteria (mainly Enterobacteriaceae, Pseudomonas aeruginosa and Acinetobacter calcoaceticus) where it acts as a potent and widespread resistance mechanism (Blanco, Mendoza & Hardisson, 1983; Fierro, Mendoza & Hardisson, 1984; Mendoza et al., 1984 and unpublished data) .
In the literature seven subclasses of AAC(3) enzymes have been described mainly based on differences in substrate profile or degree of aminoglycoside modification (Davies & Smith, 1978; Gomez-Lus et al., 1980; Bryan, 1984; Hare & Miller, 1984; 334 F. Jarfer Teran et aL Lopez-Cabrera et al., 1989) , although in some cases immunological cross-reactions and kinetic tests have also been done (Davies & Smith, 1978) . It should be emphasized that with the conventional classification criteria, the assignment of several enzymes to a subclass does not necessarily imply evolutionary relatedness among them. The development of recombinant DNA technology has enabled the cloning and characterization of some genes encoding aminoglycoside modifying enzymes as well as other antibiotic resistance genes and the design of DNA probes consisting of structural genes or their intragenic fragments (Cooksey & Mayer, 1985; Tenover, 1986; Halbert, 1988) . The application of these probes can be a very specific and useful tool in epidemiological studies and helps to answer questions concerning the diversity of isoenzymes and the molecular relationship among proteins with different specificity. When this study started, structural genes for AAC (3)m and AAC (3)FV isoenzymes had been cloned and sequenced (Brau, Pilz & Piepersberg, 1984; Allmansberger, Brau & Piepersberg, 1985) . Recently, DNA probes for another three AAC (3) enzymes, initially defined as AAC (3)V (Barg, 1988) , AAC (3)1 (Tenover et al., 1989) and AAC (3)11 (Vliegentbart, Ketelaar-van Gaalen & van de Klundert, 1989) have been developed, and the genes for the latter two were cloned and sequenced. In this paper data are presented on the isolation and characterization of the responsible genes for two prevalent and endemic AAC (3) enzymes carried by Gram-negative bacteria populations in our hospitals. The data include: (i) the cloning and nucleotidc sequence ofaacCl and aacCl genes; (ii) the development and evaluation of DNA probes using genetically and enzymatically defined bacterial strains, and (iii) the assay of the probes on a series of 89 gentamicinresistant Gram-negative bacteria isolated in our hospitals.
Materials and methods

Bacterial strains, plasmids and culture conditions
Escherichia coli K12 W3110 was used as a recipient of plasmids pUO901 and pUO055, which were used as sources for aacCl and aacCl genes, respectively. E. coli HB101 and E. coli K12 JM83 were the recipients in transformation experiments. Other strains and plasmids used are listed in Table I . In addition, the 89 strains of Gram-negative bacteria isolated during the period of October-December 1987 on the basis of their gentamicin resistance in the Microbiology laboratories of the hospitals 'Covadonga' and 'General' of Oviedo, were used for epidemiological surveys (Table III) ; negative controls included gentamicin susceptible strains isolated in the same period and plasmid free strains such as E. coli K12 C600, W3110 and 185. The cloning vectors, pBR322, pUC18 and pUC19, have been described elsewhere (Bolivar et al., 1977; Yanisch-Perron, Vieira & Messing, 1985) . Bacteria were cultured in Luria broth or on Mueller-Hinton agar (Difco). Detection of/J-galactosidase non-producing colonies was performed with agar supplemented with 0004% 5 bromo-4 chloro-3 indolyl-/?-D-galactopyranosidc (X-gal).
Determination of antibiotic susceptibility. Testing was carried out by disc diffusion or agar-dilution on agar plates using the concentrations recommended in (Lennette et al., 1980; Shimizu et al., 1985) .
Assay of aminoglycoside-modifymg enzymes. The activity of the aminoglycosidemodifying enzymes was detected by the phosphocellulose paper binding technique (Haas & Dowding, 1975) using (ll4 Q-acetyl Coenzyme A (50-6 mCi/mmole, New 
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Neither of the plasmids conferred resistance (C1M < 2 mg/L) to apramycin, amikacin or 5-episisomicin nor was associated with acetylating activity against these aminoglycojide substrates.
•GmCx, gentamicin C complex; GrnCI, gentamicin Cl; GmCla, gentamicin Cla; DKB, deoxykanamycin; KmA, kanamycin A; Nm, neomycin; Net, netilmidn; Pm, paromomycin; Si, sisomicin; Tb, tobramydn.
Acetylation rate expressed as percentage of activity (counts per minute) against GmCla as substrate.
England Nuclear) and each of the antibiotics indicated in Table II as substrates and a S100 cell extract as a source of enzyme. Assays were performed in triplicate. Preparation and electrophoresis of plasmid DNA. Plasmid DNA was isolated by the cleared lysate method (Clewell & Helinski, 1969) , followed by caesium chlorideethydium bromide centrifugation (Maniatis, Fritsch & Sambrook, 1982) . For smallscale preparations the alkaline method of Birnboim & Doly (1979) was used. Electrophoresis of plasmid DNA was performed in 07-1% agarose gels by using a Tris-borate buffer (pH 8) system.
Conjugation. Conjugation was performed with liquid medium as previously described (Havekes, Lugtenberg & Hoedstra, 1976) using as a recipient E. coli K12 W3110 resistant to rifampicin and selecting the transconjugants on agar plates containing rifampicin (30mg/L) and gcntamicin (lOmg/L).
Molecular cloning. Treatment of DNA with restriction endonuclcascs, and DNA ligase (all supplied by Boehringer Mannheim GmbH) were performed as recommended by the supplier. Plasmid transformations were done as described in Hanahan (1983) .
Minicell analysis of plasmid-encoded proteins. E.coli PAP256 was used to produce minicells. This strain was transformed with pUC18 and pBR322 as well as with derivatives of the clinical plasmids which carried aacCl and aacCl, pUO90C3 and pUO55C4, respectively. Isolation and purification of minicells, labelling of plasmidencoded proteins with ( 35 S)-methionine (1129 Ci/mmol, New England Nuclear, Drcieich, West Germany), polyacrylamide gel elcctrophoresis and fluorography were performed as described in Villar, Hardisson & Suarez (1986) .
Preparation and assay of probe DNA. Plasmids pUO90C3 and pUO55C4 were digested with EcoRV-Aval and SaR-Nrul respectively; the DNA fragments were separated by slab gel electrophoresis in low melting point agarose and the fragments of interest were excised and purified by passage through Elutip-D columns (Schleicher and Schuell, Inc. Keene, NH). The probes were nick translated using ("PJ-dCTP (3000 Ci/mmol, New England Nuclear) as described in Maniatis et al. (1982) , and hybridized to DNA immobilized on nitrocellulose or nylon filters (Zeta-probe, BioRad, Richmond, CA) by one of the following methods: 'in-situ' lysis, dot-blot or Southern transfer (Maniatis et al., 1982) . Hybridization conditions were: 6 x salt-sodium citrate buffer pH7(SSQ, 68°C, overnight, in the absence of formamide as described in Maniatis et al. (1982) .
DNA sequencing. DNA sequences were determined after cloning into the replicative forms of phages M13mpl8 and M13mpl9, by the dideoxy-chain termination method of Sanger, Nicklen & Coulson (1977) , using (*S)-dATP (600 mCi/mmol, Amersham, Aylesbury, UK). Sequencing reactions were catalyzed by the modified T7 DNA polymerase I method (Sequenase; US Biochemical Corp. Cleveland, OH) and were primed with a universal M13 primer. Electrophoresis was on 6% vertical polyacrylamide gels containing 8 M urea. After drying, gels were exposed to Agfa Curix RP2 film.
Resuto
Resistance pattern and A AC activity encoded by plasmids pUO901 and pUO0S5
Two conjugative plasmids, pUO901 and pUO055, obtained from clinical strains of Serratia marcescens and E. coli isolated from urine cultures in 1975 and 1979 respectively, were chosen as sources of aacC. After conjugation to E.coli K12 W3110, pUO901 was determined to have a mass of 72kbp and to confer resistance to semisynthetic penicillins such as ampicillin and carbenicillin; chloramphenicol; tetracycline; sulphadiazine; streptomycin; spectinomycin; kanamycin, neomycin, paromomycin; and gentamirin, sisomicin, but not to tobramycin, netiknicin, dibekacin and amikacin. Plasmid pUOOSS, of 74 kbp, conferred resistance to semisynthetic penicillins, and to a broad range of deoxystreptaminic aminoglycosides of clinical use (Table II) , but not to neomycin, paromomycin, amikacin, 5-episisomicin and apramycin.
The acetyltransferase activity of extracts of E. coli K.12 W3110 carrying pUO901 or pUOOSS was determined by the phosphocellulose paper binding assay. The data (Table  II) , were consistent with an AAC(3) enzymatic activity in both cases, because only compounds with an amino group in the C3 were acetylated. The substrate profile of both plasmids was also consistent with absence of AAC (20 and AAC (60 activities. Plasmid pUO901 also encodes for APH (30 and ANT (3*) activities as judged by the resistance conferred against kanamycin-neomycin-paromomycin and streptomycinspectinomycin respectively, which corresponded with the modification of the same antibiotics when ATP was used as a substrate (data not shown).
Cloning and nucleotide sequence of the aacC7 gene
Plasmid pUO901 was digested with BamHl, the fragments were ligated to pBR322 linearized with the same enzyme and the corresponding ligation mix used to transform E. coli HB101 competent cells. Analysis of several clones resistant to .gentamicin and ampicillin but susceptible to tetracycline, showed a single 8 kbp plasmid which, upon transformation, reproduced the phenotype. This plasmid was named pUO90Cl and both the resistance pattern and aminoglycoside modification capacity that it conferred indicated that in its 3-6 kbp insert there was information for AAC (3)1 and ANT (3") activities, as was later confirmed by Bristol-Myers laboratory, Syracuse, New York, USA (data not shown). The restriction map of pUO90Cl (Figure 1 ) showed no sites for Xhol, Xbal, Hpal and Kpn\. Sites for HindUl and EcoRl, present in the insertion, were used together with homologous sites in the vector to generate the deletion derivatives pUO90C2 (lacking a 1-5 kbp EcoRI segment) and pUO90C3 (devoid of a 1-8 kbp HindlU fragment). Both mediated resistance to gentamicin and sisomicin but not to streptomycin or spectinomycin, which indicates that the deleted segments carried all or part of the aadA determinant. No deletion derivatives coding for resistance to gentamicin could be obtained after self ligation of the fragments generated from pUO90Cl with EcoKV (pUO90C4) or BgHl-BamHI (pUO90C5 and pUO90C6). It was then assumed that both EcoRV and BglU. sites were included in the aacCX determinant. To further locate the limits of the aacd, a PVMII-PVWII segment of pUO90C3 was deleted. The resulting plasmid (pUO90C7) still retained gentamicin resistance, indicating that the AAC(3)I activity was encoded by a gene located in the l-68kbp segment which extends between the restriction sites Pvull and Hin&lll as was further confirmed by enzyme assay.
Subcloning into Ml3. of segments of DNA limited by each of those sites and the BglQ. and £coRV sites, previously shown to be located in the resistance gene, allowed the sequencing of a 957 bp DNA fragment which contained two open reading frames (ORF) of 330 and 531 nucleotides respectively (Figure 2 ). The small ORF was completely included in the big one and read in the opposite direction. Minicell analysis of the expression products of plasmid pUO90C3 revealed a single polypeptide of around 19,000 daltons in addition to those of pBR322 (data not shown), indicating that in this system only the 531 bp ORF was translated, which corresponded to a 19,392 daltons polypeptide.
Cloning and nucleotide sequence of the aacC2 gene
Plasmid pUO055 was digested and the resulting fragments were ligated to linearized pBR322 in the same way as described for pUO901. A BamHI generated recombinant plasmid showing resistance to gentamicin, sisomicin, tobramycin, netilmicin, dibekacin and ampicillin and sensitivity to tetracycline was isolated. The plasmid, which had a 16kbp insertion, was named pUO55Cl and subjected to 'in-vitro' deletions as described above. In this way, three derivatives were obtained: pUO55C2, after Hindlll digestion (12-56 kbp), pUO55C3 after Aval digestion (6-6 kbp) and pUO55C4 after Pvull digestion (4-5 kbp) (Figure 3 ). All conferred a phenotype compatible with the presence of either AAC (3)11 or AAC (3)V isoenzymes (Foster, 1983; Gomez-Lus et al., 1980; Barg, 1988) . pUO55C2 was assayed by Bristol-Myers and shown to encode AAC (3)11 activity. No plasmids encoding resistance to gentamicin were obtained after Clal or Sacll digestions, which was taken as evidence that there were sites for those enzymes in the aacCl gene. Recovery of the Hpal-SaH fragment of pUO55C4 and its cloning into the polylinker of pUC18 allowed the location of the gene to this 1 kbp segment. Sequencing of this fragment gave the data shown in Figure 4 . Only one ORF, of 858 nucleotides, corresponding to a polypeptide of 286 aminoacids and a M r of 30,574 daltons, was found. It contained Sacl and Clal sites as expected, and its stop codon was only five nucleotides away from the Sal I end.
Use of&acC segments as probes
In order to test the utility of the aacC\ and aacCl sequences as probes, a search for restriction fragments was undertaken and subsequently segments of 200 bp or more Nrul-Sall) . The Aval-EcoRV and the Nrul-Sall segments of aacCl and aacC2, respectively, were probed after 'in vitro' radioactive labelling, against (i) DNA of standard strains containing several classes of aacC genes (cited in Table II) , and (ii) against 89 Gram-negative gentamicinresistant clinical isolates. The first experiment rendered positive hybridization only when the DNA being probed contained known homologous sequences, regardless of whether it was performed with isolated plasmid DNA (southern blots) or with total DNA (dot blots). However, two exceptions were detected corresponding to hybridization between the Nrul-Sall fragment from aacC2 obtained in this study and plasmids pUZ4::Tn2922, described as a prototype of an AAQ3)V activity (G6mez-Lus et al., 1980; Martin et al., 1987) and pWP866, described as carrying an AAC (3)111 activity (AUmansberger et al., 1985) . Radiochcmical testing of the acetylating activity encoded by these plasmids (gentamicin, sisomicin, tobramycin, netilmicin, deoxykanamycin B and weakly to kanamycin) confirmed that they indeed carry AAC(3)II determinants, which further confirmed the specificity of the probe.
Colony hybridization of the hospital gentamicin-resistant strains (using stringent conditions: incubation at 68°C and washes in 01 x salt-sodium citrate buffer at the same temperature) was positive with representatives of all species tested and with both probes. AU isolates positive with either probe, in at least two out of three experiments, were lysed and their plasmid DNA tested again. The data indicate a better concordance between the data of colony and blot hybridizations with aactt than with aacCl derived probes (Table III) . This could indicate that the aacC\ derived probe was not specific or that an aacCl related sequence was present in the chromosome or in another replicon not recovered with alkaline extraction.
To test these possibilities, standard E. coli K12 strains such as C600, W3110 and 185, and seven gentamicin-susceptible clinical isolates (three P. aeruginosa, two S. marcescens, one Enterobacter aerogenes and one E. coli) free of plasmids, were subjected to colony hybridization and their DNA extracted, blotted and tested against the aacCl probe. Lysed colonies of all E. coli K12 and of one P. aeruginosa strain gave positive hybridization and the rest were clearly negative. Dot blots were positive with E. coli K12 C600 and E. coli K12 185, exclusively.
Discussion
Resistance to aminoglycosides is a matter of concern in Spain. The study of such resistance led to the characterization of two endemic aacC genes with the ultimate objective of using them, or internal segments, as molecular probes in epidemiological studies. These genes, named aacCl and aacd (following the nomenclature proposed in Novick et al. (1976) , show the following features: (i) aacCl confers resistance only to gentamicin and sisomicin, while aacd also confers high levels of resistance to tobramycin, deoxykanamycin B and netilmicin; (ii) aacCl is encoded in an ORF of 531 nucleotides, while aacC2 has 858 bp; consequently, their genie products are polypeptides of 19 and 31 kdal respectively; (iii) no significant homology was found between them, and their G-f-C contents are 54-4% and 59-9%, respectively; (iv) no similarities in the sequences of their surrounding regions were found.
Comparison of the nucleotide sequences of the genes in this study with other aacC published sequences showed a remarkably strong similarity between this aacCl and a sequence encoding for the same activity, published by Tenover et al. (1989) . Only four mismatches were detected between both aacCl genes; three of the changes were silent mutations while the fourth, a transversion G-C, resulted in a change from alanine to proline. The gene described by Tenover et al., shows extensive homology in both its 5' and 3' ends with other genes of resistance, presenting minor changes with respect to them. The gene in this study is so similar to that of Tenover et al. , that both share those minor changes, namely a GGG triplet deleted from the control region which probably results in a mRNA 116 nucleo tides longer, a 19 bp direct repeat comprising the start of translation and a 48 bp insertion to the end of the sequence which allows the formation of a 107 bp inverted repeat. This homology is abruptly broken after nucleotide 856, coinciding with the 3' hot recombinational spot (GGCGTT) denned by Ouellette, Bissonette & Roy (1987) as a site of integration of resistance genes into Tn21. The similarity of the genes does not extend to the surrounding regions, shown by their restriction maps. In spite of this, the possibility exists that both segments are part of Tn21 derivatives, as judged by the resistance to mercury and sulphonamides that the original clinical plasmids pJR88 (Tenover et al., 1989) and pUO901 conferred to bacteria harbouring them.
Comparison of the sequence of the aacd of this study with other aacC genes revealed its strong similarity with the three aactt sequences published by Allmansberger et al. (1985) and its identity with the sequence recently published by Vliegenthart et al. (1989) , although in the latter case they ascribed the activity to an aacCl gene, confirmed by our data. In our hands, the plasmid pW866, carrier of one of the aacd genes described by Allmansberger et al., did not express resistance to kanamyedn, neomycin, or paromomycin, and consequently it conferred an AAC (3)11 phenotype to the host bacteria. Two interesting features of the sequence of the aacd gene in this study deserve comment* the first refers to the promoter structure and its relation to the expression of the gene; Allmansberger et al. (1985) published the sequence of three genes isolated from bacteria from different geographic locations, which showed identity in two cases and a strong similarity between those and the third. The 5' surrounding regions were not as similar, and the dissimilarity started at a point located between the putative -10 and -35 sequences. In two of the cases IS 140 insertions in opposite directions could be recognized. The insertions appear to have occurred in such a way that a palindromic hexanucleotide with a putative -35 sequence (TTGCAA) was placed 17 nucleotides before the -10 region of the gene, originating a functional promoter for the aacC gene. In the third case, no discernible -35 region could be observed. The consequence was that the level of gentamicin resistance was twice as much in the cells containing the gene with the IS 140 generated promoters than in the third case. In the gene in this study the complete homology with two of the sequences published by Allmansberger et al. (1985) is also broken between the putative -35 and -10 sequences, but once again the sequence at the 5' end of the segment provides a -35 region (TTACCA), located 17bp upstream of the -10 sequence, which restores a functional promoter. This new promoter seems to be stronger than those generated after insertion of IS 140, since pUO55C2 confers higher levels of resistance than pWP866, e.g. 1024 versus 64 mg/L gentamicin and 256 versus 16mg/L netilmicin. No differences in expression due to the surrounding regions are expected because both pWP866 and pUO55C2 are pBR322 derived plasmids, in whose tetracycline resistance gene the aacd. containing sequences have been inserted. The second characteristic of interest in the sequence obtained in this study is that although F. Javier Tertn et aL the G+C content of its common segment is 61%, it drops to 44-7% in the nonhomologous region, possibly indicating different origins for both segments. The high G + C content of the aacC gene moved Allmansberger et al. (1985) to propose its streptomycete origin, which was later confirmed by comparison of its predicted aminoacid sequence with that of a gene isolated from Streptomyces rimosus (LopezCabrera et al., 1989) .
The use of probes derived from the aacCl and aacC2 genes described here is interesting from an epidenuological point of view, since both genes are endemic in hospitals in Spain (their phenotypes have been continuously detected, through acetylation assays, since 1975). In fact, aacC2 is the most frequent determinant of resistance to aminoglycosides (60-7% of the gentamicin resistant population), presumably because it has a broad substrate profile which includes some clinically important agents such as gentamicin, tobramycin and netilmicin, the first two of which are used routinely; the consumption of gentamicin and tobramycin during the period 1985-87, expressed in 'defined daily doses per 100 beds' (Nordic Council on Medicines, 1985) was 3-85 and 0-46 g, respectively, whereas netilmicin is used sporadically (data from the Service of Pharmacy of the Hospital Covadonga). The good correlation between hybridization data from colony and, dot or Southern, blots when aacCl is used as a probe, enable it to be used in epidemiological surveys, even using 'in-situ' lysis of the problem strains, confirming and extending the data of Vhegenthart et al. (1989) . Its use, together with acetylation assays, has even allowed the redefinition of the resistance to gentamicin carried by plasmids pUZ4::Tn 2922 (Martin et al., 1987) and pWP866 (Allmansberger et al., 1985) as due to an aacd activity. In contrast, in this study only negative data with colony hybridization using the segment Aval-EcoKV of the gene aacCl as probe against gentamicin resistant strains could be relied upon. From the colonies with positive hybridization, DNA should be prepared and subjected to another hybridization to confirm the genotype. This is so even though the aacCl derived probe is much smaller than the aacC2-containing sequence. This data indicates that not only the size of the probe and its intragenic nature are important to get a good specificity, but that other variables could also be influential, e.g. the presence in the cell of related sequences.
All the above data, considered together, confirm the statement of Vliegenthart et al. (1989) that the classification of aminoglycoside modifying enzymes has to be done through the determination of structural homologies and range of substrates rather than by the level of resistance or the degree of substrate modification and on the other hand, that the definition of a sequence as a useful probe has to be individually tested against the prevalent strains of the environment in which it is going to be used.
